Literature DB >> 11522849

ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?

J T Kielstein1, J C Frölich, H Haller, D Fliser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11522849     DOI： 10.1093/ndt/16.9.1742

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  10 in total

1.  Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.

Authors:  Tariq Shafi; Thomas H Hostetter; Timothy W Meyer; Seungyoung Hwang; Xin Hai; Michal L Melamed; Tanushree Banerjee; Josef Coresh; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2017-01-12       Impact factor: 8.860

2.  Effect of febuxostat on oxidative stress in hemodialysis patients with endothelial dysfunction: a randomized, placebo-controlled, double-blinded study.

Authors:  Mona Alshahawey; Sara M Shaheen; Tamer Elsaid; Nagwa Ali Sabri
Journal:  Int Urol Nephrol       Date:  2019-08-01       Impact factor: 2.370

3.  Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?

Authors:  Antonio Aversa; Roberto Bruzziches; Davide Francomano; Marco Natali; Andrea Lenzi
Journal:  Ther Adv Urol       Date:  2009-10

4.  Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial.

Authors:  Vladimir Teplan; Otto Schück; Jaroslav Racek; Olga Mareckova; Milena Stollova; Vladimir Hanzal; Jan Malý
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

5.  Nitric oxide manipulation: a therapeutic target for peripheral arterial disease?

Authors:  Gareth Williams; Xu Shi-Wen; David Abraham; Sadasivam Selvakumar; Daryll M Baker; Janice C S Tsui
Journal:  Cardiol Res Pract       Date:  2012-03-20       Impact factor: 1.866

Review 6.  A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations.

Authors:  Corina Serban; Amirhossein Sahebkar; Sorin Ursoniu; Dimitri P Mikhailidis; Manfredi Rizzo; Gregory Y H Lip; G Kees Hovingh; John J P Kastelein; Leszek Kalinowski; Jacek Rysz; Maciej Banach
Journal:  Sci Rep       Date:  2015-05-13       Impact factor: 4.379

7.  Homocystein as a risk factor for developing complications in chronic renal failure.

Authors:  Biljana Jakovljevic; Branislav Gasic; Pedja Kovacevic; Zvezdana Rajkovaca; Tijana Kovacevic
Journal:  Mater Sociomed       Date:  2015-04-05

Review 8.  The Diverse Efficacy of Food-Derived Proanthocyanidins for Middle-Aged and Elderly Women.

Authors:  Toru Izumi; Masakazu Terauchi
Journal:  Nutrients       Date:  2020-12-15       Impact factor: 5.717

9.  Associations of proanthocyanidin intake with renal function and clinical outcomes in elderly women.

Authors:  Kerry L Ivey; Joshua R Lewis; Wai H Lim; Ee M Lim; Jonathan M Hodgson; Richard L Prince
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

10.  Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function.

Authors:  Mauro Sergio Martins Marrocos; Andrei Alkmin Teixeira; Beata Marie Quinto; Silmara de Melo Carmona; Mariana Kuniyoshi; Cassio Jose Rodrigues; Maria Aparecida Dalboni; Silvia Manfredi; Maria Eugênia Canziani; Marcelo Costa Batista
Journal:  Lipids Health Dis       Date:  2016-01-20       Impact factor: 3.876
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.